25 related articles for article (PubMed ID: 15853805)
1. The thymidine kinase/ganciclovir-mediated "suicide" effect is variable in different tumor cells.
Beck C; Cayeux S; Lupton SD; Dörken B; Blankenstein T
Hum Gene Ther; 1995 Dec; 6(12):1525-30. PubMed ID: 8664377
[TBL] [Abstract][Full Text] [Related]
2. Genetic models for lineage tracing in musculoskeletal development, injury, and healing.
Loder S; Patel N; Morgani S; Sambon M; Leucht P; Levi B
Bone; 2023 Aug; 173():116777. PubMed ID: 37156345
[TBL] [Abstract][Full Text] [Related]
3. Exogenous aralar/slc25a12 can replace citrin/slc25a13 as malate aspartate shuttle component in liver.
González-Moreno L; Santamaría-Cano A; Paradela A; Martínez-Chantar ML; Martín MÁ; Pérez-Carreras M; García-Picazo A; Vázquez J; Calvo E; González-Aseguinolaza G; Saheki T; Del Arco A; Satrústegui J; Contreras L
Mol Genet Metab Rep; 2023 Jun; 35():100967. PubMed ID: 36967723
[TBL] [Abstract][Full Text] [Related]
4. A Herpes Simplex Virus Thymidine Kinase-Induced Mouse Model of Hepatocellular Carcinoma Associated with Up-Regulated Immune-Inflammatory-Related Signals.
Gong Z; Ma Q; Wang X; Cai Q; Gong X; Genchev GZ; Lu H; Zeng F
Genes (Basel); 2018 Jul; 9(8):. PubMed ID: 30060537
[TBL] [Abstract][Full Text] [Related]
5. Recapitulation of treatment response patterns in a novel humanized mouse model for chronic hepatitis B virus infection.
Winer BY; Huang T; Low BE; Avery C; Pais MA; Hrebikova G; Siu E; Chiriboga L; Wiles MV; Ploss A
Virology; 2017 Feb; 502():63-72. PubMed ID: 28006671
[TBL] [Abstract][Full Text] [Related]
6. The nude mouse as model for liver deficiency study and treatment and xenotransplantation.
Vidal I; Richert L
Int J Hepatol; 2012; 2012():140147. PubMed ID: 23193481
[TBL] [Abstract][Full Text] [Related]
7. A novel murine model to deplete hepatic stellate cells uncovers their role in amplifying liver damage in mice.
Puche JE; Lee YA; Jiao J; Aloman C; Fiel MI; Muñoz U; Kraus T; Lee T; Yee HF; Friedman SL
Hepatology; 2013 Jan; 57(1):339-50. PubMed ID: 22961591
[TBL] [Abstract][Full Text] [Related]
8. The reconstituted 'humanized liver' in TK-NOG mice is mature and functional.
Hasegawa M; Kawai K; Mitsui T; Taniguchi K; Monnai M; Wakui M; Ito M; Suematsu M; Peltz G; Nakamura M; Suemizu H
Biochem Biophys Res Commun; 2011 Feb; 405(3):405-10. PubMed ID: 21238430
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of human hepatocyte transplantation in a SCID/uPA mouse model with inducible liver disease.
Douglas DN; Kawahara T; Sis B; Bond D; Fischer KP; Tyrrell DL; Lewis JT; Kneteman NM
PLoS One; 2010 Feb; 5(2):e9209. PubMed ID: 20174638
[TBL] [Abstract][Full Text] [Related]
10. High mobility group box2 promoter-controlled suicide gene expression enables targeted glioblastoma treatment.
Balani P; Boulaire J; Zhao Y; Zeng J; Lin J; Wang S
Mol Ther; 2009 Jun; 17(6):1003-11. PubMed ID: 19240692
[TBL] [Abstract][Full Text] [Related]
11. [Construction and identification of recombinant vectors carrying herpes simplex virus thymidine kinase genes expressed in vascular endothelial cells].
Liu XP; Li BJ; Zhang C
Ai Zheng; 2006 Feb; 25(2):179-84. PubMed ID: 16480582
[TBL] [Abstract][Full Text] [Related]
12. Enhanced antitumor effects of a bicistronic adenovirus vector expressing both herpes simplex virus thymidine kinase and monocyte chemoattractant protein-1 against hepatocellular carcinoma.
Tsuchiyama T; Kaneko S; Nakamoto Y; Sakai Y; Honda M; Mukaida N; Kobayashi K
Cancer Gene Ther; 2003 Apr; 10(4):260-9. PubMed ID: 12679798
[TBL] [Abstract][Full Text] [Related]
13. [Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines].
Kang Y; Xu CJ; Liu XS; Wu CQ; Zhong CP; Gu JR
Ai Zheng; 2005 Aug; 24(8):909-14. PubMed ID: 16086864
[TBL] [Abstract][Full Text] [Related]
14. [A study on selective killing effect of Hsv-tk/GCV driven by human telomerase catalytic subunit promoter on human lung cancer cell A549].
Tang XJ; Wang YP; Zhou QH; Che GW; Chen XH; Zhu DX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Apr; 24(2):148-52. PubMed ID: 17407070
[TBL] [Abstract][Full Text] [Related]
15. Development of an HSV-tk transgenic mouse model for study of liver damage.
Zhang Y; Huang SZ; Wang S; Zeng YT
FEBS J; 2005 May; 272(9):2207-15. PubMed ID: 15853805
[TBL] [Abstract][Full Text] [Related]
16. The effect of HSV-tk/GCV on hepatic specific damage driven by murine ALB promoter/enhancer.
Zhang Y; Huang SZ; Zeng YT
Yi Chuan Xue Bao; 2004 Oct; 31(10):1053-60. PubMed ID: 15552038
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
